Vaccines for COVID-19

Dear Colleagues,

Three years after the spread of SARS-CoV-2, the virus responsible for the last global pandemic event, we can take stock of the past, present, and future of the SARS-CoV-2 virus. This includes, on one hand, the about 7 million deaths around the world caused by the virus (though this number could be an underestimation), but also, on the other, the vast range of pharmacological measures and vaccine options that did not exist in 2020. Because of the pandemic, health systems globally bordered on collapse, having to deal with extreme numbers of simultaneous cases. The situation today is far more manageable, though the virus continues to circulate and remains challenging to eradicate.

The topics that I invite you to reflect on are as follows:

1. The impact of vaccination on the general population;
2. The impact of vaccination on the elderly population;
3. The impact of vaccination on the population of so-called fragile subjects (immunosuppressed, sick, those with oncological problems or heart disease, etc.).

Dr. Filippo Luciani
Dr. Erika Cione
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.